After nearly 21 years at Abbott Laboratories (NYSE: ABT), CEO Miles White is preparing for his departure. The company announced Wednesday that White will leave March 31 and be replaced by Robert Ford, Abbott's current president and COO.
White will leave a stark print on his longtime corporate home.
Since he joined the team in 1998, White has helped Abbott achieve 402% stock growth and create about $200 billion in shareholder value. The last five years have seen 92% growth.
The value came from international expansion and sales growth, as well as adaptation of Abbott to consumer demands.
White also built Abbott as the world leader in blood screening diagnostics, adult nutrition and drug eluting stents.
The company also operates divisions specializing in medical devices, glucose monitoring and generic drugs.
In 2001, he acquired BASF's pharmaceutical division to get Humira in the Abbott portfolio.
Through Abbott, White became the youngest leader of a major health company. By March 2019, he had become the sixth longest-serving CEO in the S&P 100. Barron's listed him among the globe's best CEOs for the last 11 years.
After vacating his executive position, White will remain on as executive chairman, according to Abbott. He also continues to serve on the boards of McDonald's Corporation (NYSE: MCD) and Caterpillar Inc (NYSE: CAT).
The stock was down 0.7% at $83.77 at the time of publication.
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
Photo courtesy of Abbott Laboratories.
See more from Benzinga
- Nike Will No Longer Sell Products Directly On Amazon
- Starbucks To Open Largest Store In Chicago: 5 Stories, Cocktail Bar, 3 Coffee Bars And More
- Barrington Downgrades Fluent After Earnings Miss, Stock Drop
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.